amyloid polyneuropathy


Also found in: Dictionary, Wikipedia.
Related to amyloid polyneuropathy: amyloidosis

polyneuropathy

 [pol″e-noo͡-rop´ah-the]
a disease involving several nerves.
amyloid polyneuropathy polyneuropathy caused by amyloidosis; symptoms may include dysfunction of the autonomic nervous system, carpal tunnel syndrome, and sensory disturbances in the extremities.
familial amyloid polyneuropathy autosomal dominant amyloid polyneuropathy occurring in hereditary amyloidosis; subtypes include Finnish type, Indiana type, Iowa type, and Portuguese type. The Finnish and Indiana types are slowly progressive, whereas in the Portuguese and Iowa types death may occur within 7 to 10 years.
erythredema polyneuropathy acrodynia.

amyloid polyneuropathy

Polyneuropathy characterized by deposition of amyloid in nerves.
See also: polyneuropathy
References in periodicals archive ?
Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) is a rare and fatal neurodegenerative disease primarily caused by a genetic mutation of the transthyretin (TTR) gene.
Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation.
Global Markets Direct's, 'Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) - Pipeline Review, H2 2012', provides an overview of the Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) therapeutic pipeline.
Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) is a rare and fatal neurodegenerative disease, primarily caused by a genetic mutation of the transthyretin (TTR) gene.
5 billion agreement for Nogra's GED-0301 to treat Crohn's disease, and Genzyme and Alnylam signed a $775 million pact to co-develop Alnylam's patisiran for transthyretin-mediated amyloidosis patients with familial amyloid polyneuropathy.
However, its malfunction often lead to devastating diseases, like the ones related to Transthyretin:famylial amyloid polyneuropathy (FAP), famylial amyloid cardiomyopathy (FAC) and systemic senyl amyloidosis (SSA), cureless to date.
Keio University Hospital surgeons removed the liver of a patient in his 20s with familial amyloid polyneuropathy (FAP), a slowly progressive disease that can eventually be fatal.
Tafamidis is a novel, investigational, oral therapy for the treatment of Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) in adult patients with symptomatic polyneuropathy to delay neurologic impairment.
Changes in renal function in patients with familial amyloid polyneuropathy treated with orthotopic liver transplantation.
Value of renal biopsy in the prognosis of liver transplantation in familial amyloid polyneuropathy ATTR Val30Metpatients.
Rx] for patients with familial amyloid polyneuropathy, FAP, and TTR amyloid cardiomyopathy.
An $18m milestone payment from GlaxoSmithKline (GSK) is gained by Isis Pharmaceuticals for the advancement of Phase II/III study of ISIS-TTR in patients with familial amyloid polyneuropathy (FAP).